1. Home
  2. IRWD vs CDMO Comparison

IRWD vs CDMO Comparison

Compare IRWD & CDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • CDMO
  • Stock Information
  • Founded
  • IRWD 1998
  • CDMO 1981
  • Country
  • IRWD United States
  • CDMO United States
  • Employees
  • IRWD N/A
  • CDMO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • CDMO Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRWD Health Care
  • CDMO Health Care
  • Exchange
  • IRWD Nasdaq
  • CDMO Nasdaq
  • Market Cap
  • IRWD 734.5M
  • CDMO 793.8M
  • IPO Year
  • IRWD 2010
  • CDMO N/A
  • Fundamental
  • Price
  • IRWD $3.66
  • CDMO $12.39
  • Analyst Decision
  • IRWD Buy
  • CDMO Hold
  • Analyst Count
  • IRWD 4
  • CDMO 3
  • Target Price
  • IRWD $12.00
  • CDMO $12.25
  • AVG Volume (30 Days)
  • IRWD 2.4M
  • CDMO 1.3M
  • Earning Date
  • IRWD 02-13-2025
  • CDMO 12-10-2024
  • Dividend Yield
  • IRWD N/A
  • CDMO N/A
  • EPS Growth
  • IRWD N/A
  • CDMO N/A
  • EPS
  • IRWD N/A
  • CDMO N/A
  • Revenue
  • IRWD $378,418,000.00
  • CDMO $150,445,000.00
  • Revenue This Year
  • IRWD N/A
  • CDMO $19.05
  • Revenue Next Year
  • IRWD N/A
  • CDMO $20.88
  • P/E Ratio
  • IRWD N/A
  • CDMO N/A
  • Revenue Growth
  • IRWD N/A
  • CDMO 6.75
  • 52 Week Low
  • IRWD $3.06
  • CDMO $5.90
  • 52 Week High
  • IRWD $15.70
  • CDMO $12.48
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 40.23
  • CDMO 61.55
  • Support Level
  • IRWD $3.56
  • CDMO $12.37
  • Resistance Level
  • IRWD $3.88
  • CDMO $12.45
  • Average True Range (ATR)
  • IRWD 0.31
  • CDMO 0.04
  • MACD
  • IRWD -0.10
  • CDMO -0.02
  • Stochastic Oscillator
  • IRWD 10.40
  • CDMO 71.43

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Share on Social Networks: